Literature DB >> 12391456

Study of factors responsible for recurrence of seizures in controlled epileptics for more than 1 years after withdrawal of antiepileptic drugs.

S J Lamdhade1, G M Taori.   

Abstract

531 epileptic patients, who had achieved remission mostly for 2 years or more were studied. The mean follow up period was 5 years. Recurrence was noted in 103 patients (19%) after gradual withdrawal of AED, over a period of 3-4 months. 424 patients (81%) did not have recurrence. The recurrence rate was influenced adversely by factors like adolescent age and later onset seizures, pre-treatment duration of symptoms more than 3 years, pre-treatment precipitating factors like emotional stress, lack of sleep and meals (however, number in each group is small), positive family history of epilepsy, focal neurodeficit, absence and myoclonic plus grandmal type of clinical seizures, paroxysmal generalized spike and wave discharges and generalized short polyspike and wave discharges in the pretreatment EEG, atrophic changes on CT brain scan (in small numbers), head trauma at birth or later and hereditary factors as etiology of epilepsy, and more than 30 number of seizures before achieving the remission. Factors like, sex, frequency of seizures, period of remission i.e. two years or more and number of drugs used to achieve remission, did not have any significant adverse effect. However, in the last parameter 95% remission was achieved by one or a combination of two drugs (72% and 23% respectively).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391456

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  2 in total

1.  Evaluation of Seizure Frequency Distribution in Epileptic Patients with Normal and Abnormal Electroencephalogram in Al-Zahra Hospital of Isfahan.

Authors:  Mohmmad Reza Najafi; Rokhsareh Meamar; Nafiseh Karimi
Journal:  Adv Biomed Res       Date:  2018-03-27

2.  Antiepileptic-drug tapering and seizure recurrence: Correlation with serum drug levels and biomarkers in persons with epilepsy.

Authors:  Sudhir C Sarangi; Sachin Kumar; Manjari Tripathi; Thomas Kaleekal; Surender Singh; Yogendra K Gupta
Journal:  Indian J Pharmacol       Date:  2022 Jan-Feb       Impact factor: 2.833

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.